YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Eli Lilly reduces cash price of Zepbound

Posted online

Eli Lilly is lowering cash prices on single-dose vials of Zepbound.

The price reduction can be found on LillyDirect, the company's direct-to-consumer platform.

Cash payments for the drug on LillyDirect now range $299 to $499, down from a previous range of $349 to $499 per month.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences